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Trophoblast cell surface antigen 2 (TROP2) is a transmembrane glycoprotein origi-
nally identified in human trophoblast cell lines and is highly expressed in a variety 
of epithelial cancers. The TROP2 gene was validated as a direct target of miR-125b1. 
The purpose of our study was: - to investigate the expression of TROP2 protein in 
normal placental tissues, in placentas affected by preeclampsia as well as in placentas 
with preeclampsia complicated by foetal growth restriction (IUGR); - to verify how 
miR-125b1 was involved in the regulation of TROP2 gene expression. TROP2 protein 
expression was assessed by immunohistochemistry and quantitative western blotting 
analyses while miR-125b1 expression was detected by quantitative real-time PCR. 
The studies were made in normal and pathologic placental tissues. Increasing expres-
sion of TROP2 was detected in physiological placental tissue, in according with the 
increasing gestational age. Probably, it means that TROP2 is related with the differen-
tiation of the cytotrophoblast in syncytiotrophoblast, that occurs during the develop-
ment of placenta. Moreover, miR-125b1 showed an unchanged expression during nor-
mal pregnancy. Higher expression of TROP2 protein was detected in placental tissues 
collected from patients with preeclampsia complicated by foetal growth restriction, 
compared with those from preeclampsia and gestational age-matched control sam-
ples. The miR-125b1 expression in samples from placentas affected by preeclampsia 
complicated by IUGR was detected higher than in normal placentas and in placen-
tas affected by preeclampsia. These results suggest that miR-125b1 is not involved I 
the overproduction of the TROP2 mRNA although the high expression of the miR-
NA. Our study suggests a possible involvement of TROP2 in the differentiation of the 
syncytiotrophoblast from villous cytotrophoblast and a possible role of this protein in 
preeclampsia complicated by foetal growth restriction.
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